AstraZeneca Financial Statements From 2010 to 2024

AstraZeneca PLC Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 106.2 B 101.1 B 67.4 B Slightly volatile Short and Long Term Debt Total 30.1 B 28.6 B 18 B Slightly volatile Total Current Liabilities 32.1 B 30.5 B 18.5 B Slightly volatile Total Stockholder Equity 41.1 B 39.1 B 22.4 B Slightly volatile Property Plant And Equipment Net 6.8 B 10.5 B 7.3 B Slightly volatile Net Debt 23.9 B 22.8 B 12.2 B Slightly volatile Accounts Payable 6.1 B 3.3 B 8 B Slightly volatile Cash 4.7 B 5.8 B 5.8 B Very volatile Non Current Assets Total 79.9 B 76.1 B 49 B Slightly volatile Cash And Short Term Investments 5.8 B 5.9 B 6.7 B Pretty Stable Common Stock Shares Outstanding 2.9 B 3.1 B 2.6 B Slightly volatile Short Term Investments 19 M 20 M 805.2 M Slightly volatile Liabilities And Stockholders Equity 106.2 B 101.1 B 67.4 B Slightly volatile Non Current Liabilities Total 33 B 31.4 B 26 B Slightly volatile Inventory 5.7 B 5.4 B 3.4 B Slightly volatile Total Liabilities 65.1 B 62 B 44.5 B Slightly volatile Total Current Assets 15.3 B 25.1 B 17.7 B Slightly volatile Short Term Debt 6.7 B 6.4 B 2.8 B Slightly volatile Capital Stock 297.3 M 388 M 328 M Slightly volatile Common Stock 297.3 M 388 M 328 M Slightly volatile Intangible Assets 40 B 38.1 B 24.3 B Slightly volatile Other Liabilities 6.7 B 9.8 B 9 B Slightly volatile Long Term Debt 11.3 B 22.4 B 14.3 B Slightly volatile Good Will 21.1 B 20 B 12.9 B Slightly volatile Other Current Assets 5.3 B 5.4 B 5.5 B Slightly volatile Property Plant Equipment 7.9 B 10.9 B 7.6 B Slightly volatile Common Stock Total Equity 280.8 M 295.2 M 323.3 M Slightly volatile Property Plant And Equipment Gross 20.1 B 19.1 B 9 B Slightly volatile Noncontrolling Interest In Consolidated Entity 21.9 M 23 M 490.3 M Very volatile Additional Paid In Capital 37.1 B 35.3 B 13.1 B Slightly volatile Long Term Investments 970 M 1.7 B 950.7 M Slightly volatile Short and Long Term Debt 5.4 B 5.1 B 4.7 B Slightly volatile Deferred Long Term Liabilities 3.1 B 4.5 B 3.1 B Slightly volatile Long Term Debt Total 17.1 B 18.6 B 15.5 B Slightly volatile Capital Surpluse 5.6 B 9.1 B 5.7 B Slightly volatile Net Invested Capital 52.1 B 66.6 B 40.9 B Slightly volatile
AstraZeneca PLC Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 5.2 B 4.9 B 2.6 B Slightly volatile Interest Expense 1.7 B 1.6 B 1.2 B Slightly volatile Total Revenue 24.2 B 45.8 B 27.7 B Slightly volatile Gross Profit 19.9 B 37.5 B 21.8 B Slightly volatile Other Operating Expenses 19 B 37.6 B 23.1 B Slightly volatile Operating Income 5 B 8.2 B 4.7 B Pretty Stable EBIT 5.8 B 8 B 5.5 B Very volatile Research Development 11.6 B 11 B 6.6 B Slightly volatile EBITDA 7.5 B 13 B 7.8 B Very volatile Total Operating Expenses 31.1 B 29.6 B 18.3 B Slightly volatile Net Income 3.5 B 6 B 3.3 B Pretty Stable Selling General Administrative 187.2 M 197 M 10.1 B Pretty Stable Cost Of Revenue 6.4 B 8.3 B 6.2 B Slightly volatile Net Income Applicable To Common Shares 3.2 B 3 B 3.2 B Slightly volatile Selling And Marketing Expenses 11.9 B 18.2 B 12.5 B Slightly volatile Net Income From Continuing Ops 6.3 B 6 B 2.8 B Slightly volatile Interest Income 342.8 M 301 M 412.6 M Pretty Stable Reconciled Depreciation 4.8 B 4.9 B 3.8 B Slightly volatile Extraordinary Items 492.8 M 554.4 M 603.7 M Slightly volatile
AstraZeneca PLC Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Free Cash Flow 6.9 B 6.6 B 3.4 B Slightly volatile Begin Period Cash Flow 4.5 B 6 B 6 B Pretty Stable Depreciation 5.2 B 4.9 B 3.6 B Slightly volatile Capital Expenditures 1.9 B 3.8 B 2.3 B Pretty Stable Total Cash From Operating Activities 10.9 B 10.3 B 5.9 B Slightly volatile End Period Cash Flow 4.1 B 5.6 B 5.6 B Very volatile Dividends Paid 3.2 B 4.5 B 3.5 B Slightly volatile Issuance Of Capital Stock 28.5 M 30 M 265.2 M Pretty Stable Stock Based Compensation 516.8 M 579 M 346.5 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 2.62 4.5546 3.5119 Slightly volatile Dividend Yield 0.0285 0.0215 0.0363 Slightly volatile PTB Ratio 9.53 5.3305 6.1077 Pretty Stable Book Value Per Share 13.27 12.6423 8.3331 Slightly volatile Free Cash Flow Yield 0.029 0.0315 0.0337 Slightly volatile Operating Cash Flow Per Share 3.51 3.3393 2.1621 Slightly volatile Average Payables 1.3 B 2.4 B 2.4 B Very volatile Stock Based Compensation To Revenue 0.0081 0.0126 0.0092 Slightly volatile Capex To Depreciation 1.32 0.7657 0.8438 Slightly volatile PB Ratio 9.53 5.3305 6.1077 Pretty Stable EV To Sales 2.78 5.0519 3.8991 Slightly volatile Free Cash Flow Per Share 2.23 2.1198 1.2395 Pretty Stable Inventory Turnover 2.54 1.5243 2.0907 Slightly volatile Net Income Per Share 2.02 1.9222 1.2856 Pretty Stable Days Of Inventory On Hand 142 239 191 Slightly volatile Payables Turnover 1.71 2.5308 2.3444 Slightly volatile Average Inventory 1.4 B 1.4 B 1.2 B Slightly volatile Research And Ddevelopement To Revenue 0.14 0.2404 0.2135 Slightly volatile Capex To Revenue 0.0635 0.0825 0.0848 Pretty Stable Cash Per Share 1.57 1.8915 2.4859 Slightly volatile POCF Ratio 26.85 20.1692 21.3115 Slightly volatile Interest Coverage 4.9 5.1561 4.4065 Slightly volatile Payout Ratio 0.71 0.7525 3.4448 Pretty Stable Capex To Operating Cash Flow 0.69 0.3652 0.5067 Very volatile PFCF Ratio 33.36 31.7725 58.0314 Pretty Stable Days Payables Outstanding 230 144 195 Slightly volatile ROE 0.14 0.1521 0.2046 Slightly volatile EV To Operating Cash Flow 28.83 22.3714 23.8531 Slightly volatile PE Ratio 58.52 35.0378 135 Pretty Stable Return On Tangible Assets 0.11 0.1385 0.1128 Slightly volatile EV To Free Cash Flow 37.0 35.2417 65.0138 Pretty Stable Earnings Yield 0.0557 0.0285 0.0431 Slightly volatile Intangibles To Total Assets 0.6 0.5749 0.5163 Slightly volatile Net Debt To EBITDA 1.84 1.7556 1.844 Slightly volatile Current Ratio 1.51 0.8203 1.1444 Slightly volatile Graham Number 24.55 23.3764 14.2064 Pretty Stable Shareholders Equity Per Share 13.27 12.6349 8.1418 Slightly volatile Debt To Equity 0.69 0.7277 1.2112 Slightly volatile Capex Per Share 1.28 1.2195 0.9226 Pretty Stable Revenue Per Share 15.53 14.7873 10.8649 Slightly volatile Interest Debt Per Share 10.19 9.7069 7.0353 Slightly volatile Debt To Assets 0.17 0.2817 0.2698 Pretty Stable Enterprise Value Over EBITDA 11.14 17.834 16.7674 Slightly volatile Short Term Coverage Ratios 1.61 1.6909 2.8772 Slightly volatile Price Earnings Ratio 58.52 35.0378 135 Pretty Stable Operating Cycle 203 306 263 Slightly volatile Price Book Value Ratio 9.53 5.3305 6.1077 Pretty Stable Days Of Payables Outstanding 230 144 195 Slightly volatile Dividend Payout Ratio 0.71 0.7525 3.4448 Pretty Stable Price To Operating Cash Flows Ratio 26.85 20.1692 21.3115 Slightly volatile Price To Free Cash Flows Ratio 33.36 31.7725 58.0314 Pretty Stable Operating Profit Margin 0.22 0.1788 0.1719 Slightly volatile Company Equity Multiplier 2.45 2.5833 3.7624 Slightly volatile Long Term Debt To Capitalization 0.26 0.3636 0.4305 Pretty Stable Total Debt To Capitalization 0.3 0.4212 0.4644 Very volatile Return On Capital Employed 0.11 0.1161 0.1183 Slightly volatile Debt Equity Ratio 0.69 0.7277 1.2112 Slightly volatile Ebit Per Revenue 0.22 0.1788 0.1719 Slightly volatile Quick Ratio 1.2 0.6427 0.9177 Slightly volatile Dividend Paid And Capex Coverage Ratio 1.42 1.2526 1.0102 Very volatile Cash Ratio 0.27 0.1912 0.3308 Slightly volatile Operating Cash Flow Sales Ratio 0.14 0.2258 0.186 Pretty Stable Days Of Inventory Outstanding 142 239 191 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 0.67 0.6348 0.5173 Pretty Stable Cash Flow Coverage Ratios 0.35 0.3632 0.3725 Slightly volatile Price To Book Ratio 9.53 5.3305 6.1077 Pretty Stable Fixed Asset Turnover 2.74 4.3621 3.7366 Slightly volatile Capital Expenditure Coverage Ratio 2.25 2.7382 2.4567 Very volatile Price Cash Flow Ratio 26.85 20.1692 21.3115 Slightly volatile Enterprise Value Multiple 11.14 17.834 16.7674 Slightly volatile Debt Ratio 0.17 0.2817 0.2698 Pretty Stable Cash Flow To Debt Ratio 0.35 0.3632 0.3725 Slightly volatile Price Sales Ratio 2.62 4.5546 3.5119 Slightly volatile Return On Assets 0.1 0.0589 0.0595 Slightly volatile Asset Turnover 0.79 0.453 0.508 Slightly volatile Net Profit Margin 0.1 0.13 0.1138 Slightly volatile Gross Profit Margin 0.87 0.8195 0.7893 Very volatile Price Fair Value 9.53 5.3305 6.1077 Pretty Stable Return On Equity 0.14 0.1521 0.2046 Slightly volatile
AstraZeneca PLC Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 197.2 B 187.8 B 133.1 B Slightly volatile Enterprise Value 218.7 B 208.3 B 149.8 B Slightly volatile

AstraZeneca Fundamental Market Drivers

AstraZeneca Upcoming Events

About AstraZeneca PLC Financial Statements

Pair Trading with AstraZeneca PLC

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AstraZeneca PLC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will appreciate offsetting losses from the drop in the long position's value.When determining whether AstraZeneca PLC ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AstraZeneca PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrazeneca Plc Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrazeneca Plc Adr Stock:

How To Invest In AstraZeneca Details

Is AstraZeneca Stock a good investment? Details

What is AstraZeneca PLC's Net Worth? Details

Largest Pharmaceuticals Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details